MAT1A expression is downregulated in cirrhotic and HCC patients, and Mat1a knockout mice developed NASH and HCC associated with the dysregulation of very low-density lipoprotein assembly and ER stress [56,57,58]. Here, MAT1A is linked to metabolic dysfunction-associated steatohepatitis.